Db. Fairweather et I. Hindmarch, THE BEHAVIORAL TOXICITY OF REVERSIBLE INHIBITORS OF MONOAMINE-OXIDASE-A - LABORATORY AND CLINICAL INVESTIGATIONS, Journal of clinical psychopharmacology, 15(4), 1995, pp. 68-75
Measuring the effect of an antidepressant on performance tests of psyc
homotor ability and cognitive processing is important in order to obta
in an objective assessment of its psychotropic activity. It is also es
sential to identify potential interference with everyday activities su
ch as driving, operating machinery, and performing domestic tasks and
to assess the extent to which central nervous system side effects may
compound the cognitive and psychomotor impairment resulting from depre
ssive illness. Older compounds such as amitriptyline impair performanc
e on these tests, whereas the newer antidepressant moclobemide appears
to have no effect. What remains to be clarified is whether these test
s are predictive of the behavioral side effects that may occur in depr
essed patients.